TrialAdvances in therapy2014

Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.

Enrico Agabiti-Rosei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.